The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Hologic Inc

Nasdaq: HOLX
Last

(U.S.) $41.66

Today's change+0.91 +2.23%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

Hologic Inc

Nasdaq: HOLX
Last

(U.S.) $41.66

Today's change+0.91 +2.23%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.

Hologic Inc up sharply

Hologic Inc closed up sharply Friday, rallying (U.S.)$0.91 or 2.23% to (U.S.)$41.66. Over the last five days, shares have gained 9.89% and are currently 1.63% off of the 52-week high. Shares have outperformed the S&P 500 by 50.83% during the last year.

Key company metrics

  • Open(U.S.) $40.85
  • Previous close(U.S.) $40.75
  • High(U.S.) $41.71
  • Low(U.S.) $40.78
  • Bid / Ask-- / --
  • YTD % change+55.80%
  • Volume4,317,954
  • Average volume (10-day)3,726,253
  • Average volume (1-month)3,355,568
  • Average volume (3-month)2,312,279
  • 52-week range(U.S.) $22.70 to (U.S.) $42.35
  • Beta1.21
  • Trailing P/E89.45×
  • P/E 1 year forward25.88×
  • Forward PEG3.33×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.47
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.05%

Based on its net profit margin of 5.05%, Hologic Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014Sep 27, 201409/27/2014
Revenue694656653661
Total other revenue--------
Total revenue694656653661
Gross profit379336339345
Total cost of revenue315320314316
Total operating expense596546556569
Selling / general / administrative167143147152
Research & development56535252
Depreciation / amortization27282829
Interest expense (income), net operating--------
Unusual expense (income)3021520
Other operating expenses, total------0
Operating income981109792
Interest income (expense), net non-operating-52-49-53-53
Gain (loss) on sale of assets--------
Other--------
Income before tax47614439
Income after tax29482928
Income tax, total17131511
Net income29482928
Total adjustments to net income--------
Net income before extra. items29482928
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items29482928
Inc. avail. to common incl. extra. items29482928
Diluted net income29482928
Dilution adjustment------0
Diluted weighted average shares293288283282
Diluted EPS excluding extraordinary itemsvalue per share0.100.170.100.10
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.170.170.140.04